Summary.-The subcutaneous growth of 2 antigenically distinct syngeneic methylcholanthrene-induced murine fibrosarcomas, designated HI and H7, were significantly augmented by the concomitant administration of E. coli endotoxin (LPS).
injected 1 day before the administration of 5000 tumour cells. In contrast, significant anti-tumour resistance resulted if LPS was administered 6 days before the inoculation of tumour cells. Preliminary evidence indicates that low doses of LPS can facilitate the "sneaking through" phenomenon. Enhancement of tumour growth could not be demonstrated with sera or plasma from tumour-bearing mice, unless the samples were contaminated with endotoxin. The results illustrate the importance of excluding endotoxin from solutions used in studies of experimental tumours.
THE SUBJECT OF the anti-tumour action of bacterial endotoxins, the lipopolysaccharide (LPS) component of the cell wall of Gram-negative bacteria, has attracted much attention ever since Coley deliberately treated patients with LPScontaining bacterial culture fluids (Coley, 1891) . However, the treatment of cancer by LPS fell from favour because of inconsistent and unpredictable results.
LPS-induced haemorrhagic necrosis of established experimental tumours is well documented (Nauts et al., 1953; Shear & Turner, 1943 , Shear, 1943 but differs from the relatively rare LPS-induced regression in several ways. For example, regression induced by LPS is dependent on the tumour being immunogenic and having grown to a certain size (Berendt et al., 1978a, b) . A therapeutic effect of LPS occurs only on subcutaneous and intradermal tumours, but not on intraperitoneal tumours, and is dependent upon thymusderived cells (Parr et al., 1973) . A prophylactic effect is achieved only when LPS is administered i.p. (Parr et al., 1973) .
Thus, bacterial endotoxins may inhibit the development of tumours, depending upon the type of tumour, dose and route of injection of LPS, and the interval between the administration of toxin and the time tumours have grown to a critical size.
Nevertheless, despite the attention given to the anti-tumour effects of endotoxins during past decades, only scant attention has been given to the fact that endotoxins may also potentiate tumour growth, especially if administered at or near the time of tumour transplantation. Few studies have been made of the augmentation of tumour growth and the prolongation of graft survival by LPS. For example, Floersheim (1967) found that the administration of pertussis vaccine concomitant with an inoculation of lymphoma cells, increased the incidence of tumour takes. Thomson et al. (1978) reported that the normal rejection of allogeneic skin grafts in CBA mice could be prevented if LPS was injected into the mice before and after skin grafting. The significance and implica-tions of this increased susceptibility has been largely overlooked in studies of experimental tumours.
Increased susceptibility also occurs for various other systems, including the provocation of certain latent infections by typhoid and pertussis vaccines (Dubos & Schaedler, 1956; Wilson, 1967) .
Our interest in the activities ofendotoxin arose from the observation that serum from tumour-bearing mice, or from hyperimmunized mice failed to enhance the growth of tumours in normal mice unless the serum contained endotoxin, and was injected at or near the time of the inoculation of tumour cells.
We wish to report that even small amounts of LPS can profoundly augment the growth of weakly antigenic tumours. Therefore, agents (e.g. immune serum, trypan blue and carrageenan) used in studies of enhancement or augmentation of tumour growth may produce effects which are difficult to interpret if such agents are contaminated with endotoxin.
The following experiments illustrate the importance of excluding LPS from solutions or preparations injected into mice concomitantly with weakly antigenic tumour cells.
MATERIALS AND METHODS
Mice.-Male inbred CBA/H-WEHI (H-2k) mice, 2-3 months old, were used in all experiments.
Tumours.-Two 3-methylcholanthrene-induced tumours designated HI and H7 were used. Tumour cells were obtained by disaggregating tumour fragments with pronase, as previously described (Kearney et al., 1975 injected i.p. with 20 ,ug LPS alone. All mice, including a group of untreated mice, were injected s.c. with 0.5 x 105 Hi tumour cells soon after LPS and plasma administration. Fig. 4 shows that NMP and TBP alone had no significant effect on the growth of the Hi tumour. However, the addition of LPS, either alone or admixed with NMP or TBP (to simulate contamination) significantly augmented tumour growth. Similar results were obtained when TBS or NMS was used (results not shown). (Neter, 1969) . Bacterial endotoxins may facilitate or inhibit the pathogenicity of infection, depending on the infecting micro-organism, dose and route of injection of endotoxin, and the interval between administration of toxin and initiation of infection (see reviews by Rowley, 1964; Nowotny, 1969; Cluff, 1970) . Characteristically, this resistance to infection by parasites, viruses, bacteria and fungi involves a transient decrease followed by a more prolonged increase in resistance to infection. The biphasic changes in resistance parallel changes in the clearance of foreign substances from the blood by the reticuloendothelial (RE) system (Halpern et at., 1953; Biozzi et al., 1955) . After i.v. injection of endotoxin and colloids, RE clearance is depressed for a few hours; this is followed by an increase in the phagocytic function of the RE cells for about 1 week. The initial depression of the RE system is often referred to as a "blockade"; its later enhancement is associated with an increase in number of phagocytic cells and an acceleration of the phagocytic activity of individual macrophages (Rowley, 1962; Austen & Cohn, 1963) .
Effect of LPS
Since macrophages are potentially important effector cells in the host response to neoplastic growth (e.g. Hibbs et al., 1978) any alteration in their numbers or function would be likely to affect tumour growth.
Leucocytic migration into areas of inflammation is also impaired by injection of LPS (Conti et al., 1961) . Therefore, the transient granulocytopenia induced by endotoxin may also influence resistance to tumours.
LPS provocation of the growth ofweakly antigenic HI tumours from relatively few cells begs a heuristic outlook. For example, vaccination by typhoid and pertussis vaccines, and diseases caused by Gramnegative bacteria (e.g. E. coli urinary-tract infections) may permit foci of weakly antigenic neoplastic cells to escape early destruction. Compelling evidence has led Hibbs et al. (1978) to propose a mechanism of non-specific immune surveillance against tumours. Therefore, under certain conditions, a temporary depression of such a mechanism by LPS may be an important factor in the carcinogenesis of tumours in man's environment. It is noteworthy that exposure to LPS not only augmented the growth of relatively large numbers of weakly antigenic HI tumour cells, but also facilitated the escape of relatively few cells from the anti-tumour mechanisms in normal mice. The greater incidence of significantly larger tumours in LPStreated mice injected with 50 HI tumour cells, than in LPS-treated mice injected with either 100 or 5 tumour cells, resembles the "sneaking through" effect (Klein, 1966; Naor, 1979) . The extent to which LPS facilitates the "sneaking through" effect could not be determined, however, since none of the control mice injected with fewer than 500 cells developed tumours 564 during the relatively short observation period. Nevertheless, it is conceivable that LPS may augment the growth of small foci of tumour cells by facilitating "sneaking through", before the subsequent activation of macrophages by LPS controls the ensuing tumour growth.
The modulation of host susceptibility to tumour growth is consistent with that reported for LPS on the susceptibility to bacterial infection (Cluff, 1970) except that the period during which provocation of tumour growth occurred was of a longer duration than that reported for bacterial infections. Thus, whilst increased susceptibility to infection persists only for several hours before and after exposure to LPS, provocation of HI tumour growth extended from one day before to at least 2 days after exposure to LPS.
The observed prophylactic effect of LPS against tumour growth is similar to that reported by many investigators (e.g. Old et al., 1961; Weiss et al., 1961; Parr et al., 1973) and is probably related to enhanced macrophage and RE activity a few days after exposure to LPS (Rowley, 1962; Cluff, 1970) . The tumoricidal effects induced in cultured macrophages by LPS are not apparent in vivo until some 6 days after the administration of LPS. In fact, the non-specific anti-tumour immunity found during the early development of syngeneic tumour isografts (Nelson & Nelson, 1978; seems to be inhibited by the effects of LPS. Similar inhibition of resistance occurs when low doses of H1 tumour cells are injected with a mixture of non-replicating mitomycin C-treated HI tumour cells, or injected alone into carrageenan-treated normal mice or trypan blue-treated (Wu & Kearney, 1980 ) normal mice. Thus, it seems that soon after administration LPS affects the same mechanisms of nonspecific resistance as those methods or agents which thwart macrophage function and augment tumour growth. Although the exact mechanism by which LPS augments tumour growth is not known, the principal mechanism responsible for the transient decreases in resistance to bacterial invasion following administration of endotoxin (Dubos & Schaedler, 1956 ) is believed to be interference with granulocytic diapedesis and exudation, as well as inhibition of phagocytosis by macrophages (Cluff, 1970) .
In the present experiments, 0-02 ,tg LPS significantly augmented the growth of low numbers of the weakly antigenic HI tumour cells. The time between tumour inoculation and the development of palpable tumours could be shortened by increasing the amount of LPS to 2 pg.
Further increasing the amount of LPS to 20 /tg only marginally altered this interval and the subsequent growth rate of tumours. The results illustrate that in studies involving augmentation of tumour growth, care should be taken to avoid contaminating serum or other agents with LPS (e.g. from glassware) since very minute amounts can significantly alter the subsequent growth of weakly antigenic tumours. Therefore, reports (e.g. Moller, 1964 ) which claim to demonstrate immunological enhancement of syngeneic tumours by immune serum without including a control of normal serum, or without a knowledge of the extent serum is contaminated with endotoxin, should be viewed with some caution.
The importance ofendotoxin contamination in reagents used in biological research has been demonstrated by several groups (Bito, 1977; Weinberg et al., 1978; ]Donahoe & Peters 1979) . Donahoe and Peters (1979) found that endotoxin contamination could account for the inhibition of anti-viral cell-mediated immune responses, measured either by the lymphocyte-transformation assay in vitro, or by the footpad-swelling assay in vivo. Endotoxin administered before tumour challenge will abrogate specific immunity acquired either by tumour excision, or by the injection of mitomycin C-treated tumour cells (Kearney & Harrop, to be published).
The phenomenon of allogeneic graft enhancement (Kaliss, 1962) though demon-strated in few syngeneic systems (Moller, 1964; Attia & Weiss, 1966; has led to the idea that humoral responses augment tumour growth. The idea has been further reinforced by the reports that sera from tumour-bearing animals can "block", in an immunologically specific manner, the anti-tumour cytotoxicity of specifically sensitized lymphocytes in vitro (Hellstrom & Hellstrom, 1969) . Similar tumour-bearer sera, however, were found not to inhibit the weak cell-mediated immunity to the H I tumour in vivo . We propose that enhancement, often attributed to antibodies to some syngeneic tumours, may in some cases be due to contamination of serum by endotoxin, especially if the serum is administered at or just before tumour grafting. This possibility is further strengthened by the observation that the normal rejection of allogeneic skin grafts in CBA mice can be prevented if LPS is injected into mice before and after skin grafting (Thomson et al., 1978) .
It is noteworthy that enhancement has been used as a sensitive test to demonstrate weak antibodies to tumour antigens (Moller, 1964) and also to detect crossreacting antigens after the administration of tumour-cell extracts (Attia & Weiss, 1966) . It is conceivable, therefore, that without adequate controls, biological products, including sera, contaminated with endotoxin may account for similar enhancement of weakly antigenic tumours. Such tumours may also be susceptible to antibody-mediated enhancement, but not necessarily share common tumour-specific antigens.
Since endotoxins, even in minute amounts, have a variety of effects (Cluff, 1970 ) the use of preparations contaminated with such ubiquitous substances can lead to erroneous conclusions in tumour research. Thus, preparations including sera or their fractions which enhance tumour growth should be tested to exclude endotoxin before the enhancing phenomenon can be regarded as being due to antibody or some other serum factor. Furthermore, positive anti-tumour effects by immune sera may be negated by the presence of endotoxin contamination, especially when tumours are weakly antigenic. Therefore, the use of endotoxin-contaminated preparations should be avoided in tumour research, unless it is shown that the particular system is insensitive to such substances.
